Actively Recruiting

Age: 18Years - 99Years
All Genders
NCT06183645

Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.

Led by Centre Hospitalier Universitaire de Liege · Updated on 2025-02-12

40

Participants Needed

1

Research Sites

226 weeks

Total Duration

On this page

Sponsors

C

Centre Hospitalier Universitaire de Liege

Lead Sponsor

S

SYSNAV

Collaborating Sponsor

AI-Summary

What this Trial Is About

ActiCIDP is a monocentric academic study. Patients with Chronic inflammatory demyelinating polyradiculoneuritis may be included on a voluntary basis. The investigators plan to include a group of approximately 40 patients with CIDP. The investigators have planned to assess patient every three months for a year. After each visit, participants will wear Actimyo for one month daily.

CONDITIONS

Official Title

Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with CIDP or possible CIDP based on 2021 EAN/PNS criteria
  • Treated with IVIg (≤1g/kg every 3-8 weeks)
  • Clinically stable disease for 3 months (per treating physician opinion)
  • No treatment withdrawal failure within 1 year
  • Age over 18 years
Not Eligible

You will not qualify if you...

  • Significant cognitive or communication disorders
  • Surgery or serious traumatic injury within 6 months
  • Non-ambulant patient
  • Current participation in a therapeutic trial
  • Positive for anti-myeline antibodies (anti-MAG) or nodo-paranodopathy
  • Other autoimmune disease requiring corticosteroids, IVIg, or plasma exchange treatment
  • Pregnancy or breastfeeding
  • Any condition that could interfere significantly with evaluation or safety, per investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHR Citadelle

Liège, Liège, Belgium, 4000

Actively Recruiting

Loading map...

Research Team

L

Laurie Medard

CONTACT

M

Margaux Poleur, Dr

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility. | DecenTrialz